|
US5087618A
(en)
|
1982-05-18 |
1992-02-11 |
University Of Florida |
Redox carriers for brain-specific drug delivery
|
|
US4469774A
(en)
|
1983-03-28 |
1984-09-04 |
E. I. Du Pont De Nemours And Company |
Positive-working photosensitive benzoin esters
|
|
US5563250A
(en)
|
1987-12-02 |
1996-10-08 |
Neorx Corporation |
Cleavable conjugates for the delivery and release of agents in native form
|
|
US5232695A
(en)
|
1987-12-23 |
1993-08-03 |
G. D. Searle & Co. |
Method of ameliorating herpes simplex virus infections using purified nerve growth factor
|
|
US5683894A
(en)
|
1988-04-29 |
1997-11-04 |
University Of California |
Recombinant nerve growth factor
|
|
US5486599A
(en)
|
1989-03-29 |
1996-01-23 |
The Board Of Trustees Of The Leland Stanford Junior University |
Construction and use of synthetic constructs encoding syndecan
|
|
US5094848A
(en)
|
1989-06-30 |
1992-03-10 |
Neorx Corporation |
Cleavable diphosphate and amidated diphosphate linkers
|
|
US5229500A
(en)
|
1989-08-30 |
1993-07-20 |
Regeneron Pharmaceuticals, Inc. |
Brain derived neurotrophic factor
|
|
US5977307A
(en)
|
1989-09-07 |
1999-11-02 |
Alkermes, Inc. |
Transferrin receptor specific ligand-neuropharmaceutical agent fusion proteins
|
|
US5527527A
(en)
|
1989-09-07 |
1996-06-18 |
Alkermes, Inc. |
Transferrin receptor specific antibody-neuropharmaceutical agent conjugates
|
|
WO1991008770A1
(en)
|
1989-12-11 |
1991-06-27 |
Immunomedics, Inc. |
Method for antibody targeting of diagnostic or therapeutic agents
|
|
CN1061623A
(zh)
|
1990-06-01 |
1992-06-03 |
里珍纳龙药品有限公司 |
睫状神经营养性因子受体
|
|
US5169764A
(en)
|
1990-08-08 |
1992-12-08 |
Regeneron Pharmaceuticals, Inc. |
Multitrophic and multifunctional chimeric neurotrophic factors, and nucleic acids and plasmids encoding the chimeras
|
|
US5948384A
(en)
|
1990-09-14 |
1999-09-07 |
Syngenix Limited |
Particulate agents
|
|
US5149794A
(en)
|
1990-11-01 |
1992-09-22 |
State Of Oregon |
Covalent lipid-drug conjugates for drug targeting
|
|
DE69218403T2
(de)
|
1991-01-07 |
1997-06-26 |
Syngenix Ltd |
Für endocytose geeignete teilchen
|
|
TW197439B
(https=)
|
1991-04-04 |
1993-01-01 |
Ueno Pharmaceutics Applic Res Co Ltd |
|
|
ZA922947B
(en)
|
1991-04-23 |
1993-01-27 |
Regeneron Pharma |
Assay systems for neurotrophin activity
|
|
FI940923A0
(fi)
|
1991-08-30 |
1994-02-25 |
Syngenix Ltd |
Nukleiinihappopolymeraasin tehostaminen
|
|
US5283253A
(en)
|
1991-09-23 |
1994-02-01 |
Florida State University |
Furyl or thienyl carbonyl substituted taxanes and pharmaceutical compositions containing them
|
|
DE69228127T2
(de)
|
1991-11-15 |
1999-09-02 |
The Regents Of The University Of California |
Therapie des zentralnervensystems mit genetisch modifizierten zellen
|
|
WO1993010076A1
(en)
|
1991-11-22 |
1993-05-27 |
The University Of Mississippi |
Synthesis and optical resolution of the taxol side chain and related compounds
|
|
US5200534A
(en)
|
1992-03-13 |
1993-04-06 |
University Of Florida |
Process for the preparation of taxol and 10-deacetyltaxol
|
|
US5470997A
(en)
|
1992-04-06 |
1995-11-28 |
Biosite Diagnostics Incorporated |
Amphetamine derivatives and protein and polypeptide amphetamine derivative conjugates and labels
|
|
JPH08500973A
(ja)
|
1992-05-21 |
1996-02-06 |
ザ ペン ステイト リサーチ ファウンデーション |
タキソール、関連タキサン及び他の新規な抗癌／抗ウイルス性化合物原料としてのイチイ培養組織
|
|
GB2267502B
(en)
|
1992-05-28 |
1997-01-22 |
Aligena Ag |
Polymeric reaction products for use in immobilized buffered gels and membranes
|
|
US5274137A
(en)
|
1992-06-23 |
1993-12-28 |
Nicolaou K C |
Intermediates for preparation of taxols
|
|
US5505931A
(en)
|
1993-03-04 |
1996-04-09 |
The Dow Chemical Company |
Acid cleavable compounds, their preparation and use as bifunctional acid-labile crosslinking agents
|
|
US5294637A
(en)
|
1992-07-01 |
1994-03-15 |
Bristol-Myers Squibb Company |
Fluoro taxols
|
|
US5202448A
(en)
|
1992-08-14 |
1993-04-13 |
Napro Biotherapeutics, Inc. |
Processes of converting taxanes into baccatin III
|
|
DE69327113D1
(de)
|
1992-09-14 |
1999-12-30 |
Regeneron Pharma |
Methode zum erzeugen von analgie mittels neurotrophine
|
|
CA2100808A1
(en)
|
1992-10-01 |
1994-04-02 |
Vittorio Farina |
Deoxy paclitaxels
|
|
FR2696464B1
(fr)
|
1992-10-05 |
1994-11-10 |
Rhone Poulenc Rorer Sa |
Nouveau procédé d'estérification de la baccatine III et de la désacétyl-10 baccatine III.
|
|
FR2696463B1
(fr)
|
1992-10-05 |
1994-11-25 |
Rhone Poulenc Rorer Sa |
Procédé d'obtention de la désacétyl-10 baccatine III.
|
|
FR2696461B1
(fr)
|
1992-10-05 |
1994-11-10 |
Rhone Poulenc Rorer Sa |
Nouveaux dérivés d'analogues du taxol, leur préparation et les compositions qui les contiennent.
|
|
FR2696458B1
(fr)
|
1992-10-05 |
1994-11-10 |
Rhone Poulenc Rorer Sa |
Procédé de préparation de dérivés du taxane.
|
|
FR2696462B1
(fr)
|
1992-10-05 |
1994-11-25 |
Rhone Poulenc Rorer Sa |
Procédé d'obtention de la désacétyl-10 baccatine III.
|
|
US5349056A
(en)
|
1992-10-09 |
1994-09-20 |
Regeneron Pharmaceuticals |
Modified ciliary neurotrophic factors
|
|
US6472178B1
(en)
|
1998-02-27 |
2002-10-29 |
Regeneron Pharmaceuticals, Inc. |
Nucleic acids encoding a modified ciliary neurotrophic factor and method of making thereof
|
|
US6410510B1
(en)
|
1996-05-13 |
2002-06-25 |
Regeneron Pharmaceuticals, Inc. |
Administration modified ciliary neurotrophic factors
|
|
US5279949A
(en)
|
1992-12-07 |
1994-01-18 |
Board Of Trustees Operating Michigan State University |
Process for the isolation and purification of taxol and taxanes from Taxus spp
|
|
IL109280A0
(en)
|
1993-04-15 |
1994-07-31 |
Regeneron Pharma |
Neurotrophins for treatment of depression
|
|
US5614487A
(en)
|
1993-05-28 |
1997-03-25 |
Genentech, Inc. |
Sustained release pharmaceutical composition
|
|
US5502037A
(en)
|
1993-07-09 |
1996-03-26 |
Neuromed Technologies, Inc. |
Pro-cytotoxic drug conjugates for anticancer therapy
|
|
WO1995007092A1
(en)
|
1993-09-10 |
1995-03-16 |
The University Of Medicine And Dentistry Of New Jersey |
Blood-brain barrier transporters of neurological agents
|
|
US5824701A
(en)
|
1993-10-20 |
1998-10-20 |
Enzon, Inc. |
Taxane-based prodrugs
|
|
US5415869A
(en)
|
1993-11-12 |
1995-05-16 |
The Research Foundation Of State University Of New York |
Taxol formulation
|
|
US5882941A
(en)
|
1994-05-04 |
1999-03-16 |
Massachusette Institute Of Technology |
Programmable genotoxic agents and uses therefor
|
|
EP0760681B1
(en)
|
1994-05-31 |
1999-09-01 |
Allergan, Inc |
Modification of clostridial toxins for use as transport proteins
|
|
US5728803A
(en)
|
1994-06-03 |
1998-03-17 |
Genentech, Inc. |
Pantropic neurotrophic factors
|
|
US7144983B1
(en)
|
1997-02-03 |
2006-12-05 |
Genentech, Inc. |
Pantropic neurotrophic factors
|
|
US5556837A
(en)
|
1994-08-01 |
1996-09-17 |
Regeneron Pharmaceuticals Inc. |
Methods for treating addictive disorders
|
|
US5661035A
(en)
|
1995-06-07 |
1997-08-26 |
The Regents Of The University Of California |
Voltage sensing by fluorescence resonance energy transfer
|
|
US6267955B1
(en)
|
1995-09-15 |
2001-07-31 |
Yeda Research And Development Co. Ltd. |
Mononuclear phagocytes and their use to promote axonal regeneration
|
|
GB9525180D0
(en)
|
1995-12-08 |
1996-02-07 |
Univ Mcgill |
Design of hormone-like antibodies with agonistic and antagonistic fuctions
|
|
WO1997023608A1
(en)
|
1995-12-22 |
1997-07-03 |
Chiron Corporation |
Compositions and methods for targeting gene delivery vehicles using covalently bound targeting elements
|
|
US5767288A
(en)
|
1996-01-05 |
1998-06-16 |
California Institute Of Technology |
Photolabile linkers and probes
|
|
US6406710B1
(en)
|
1996-01-16 |
2002-06-18 |
Nikos Panayotatos |
Protein occlusion for delivery of small molecules
|
|
WO1997026275A1
(en)
|
1996-01-16 |
1997-07-24 |
Nikos Panayotatos |
Protein occlusion for delivery of small molecules
|
|
US5994317A
(en)
|
1996-04-09 |
1999-11-30 |
Vical Incorporated |
Quaternary cytofectins
|
|
US5795909A
(en)
|
1996-05-22 |
1998-08-18 |
Neuromedica, Inc. |
DHA-pharmaceutical agent conjugates of taxanes
|
|
US6576636B2
(en)
|
1996-05-22 |
2003-06-10 |
Protarga, Inc. |
Method of treating a liver disorder with fatty acid-antiviral agent conjugates
|
|
JPH10212241A
(ja)
|
1996-05-27 |
1998-08-11 |
Sumitomo Pharmaceut Co Ltd |
Ｂｄｎｆを安定に含有する製剤
|
|
US6197743B1
(en)
|
1996-07-26 |
2001-03-06 |
The Trustees Of Boston University |
Compositions and methods for the treatment of viral disorders
|
|
EP0961619A4
(en)
|
1996-09-27 |
2001-09-26 |
Bristol Myers Squibb Co |
HYDROLYSABLE DRUGS FOR THE RELEASE OF ANTI-CANCER DRUGS IN METASTATIC CELLS
|
|
AU4966597A
(en)
|
1996-11-19 |
1998-06-10 |
Daiichi Pharmaceutical Co., Ltd. |
Taxol derivatives
|
|
US5977386A
(en)
|
1996-12-24 |
1999-11-02 |
Bristol-Myers Squibb Company |
6-thio-substituted paclitaxels
|
|
IL133585A0
(en)
|
1997-06-20 |
2001-04-30 |
Baker Norton Pharma |
Soluble prodrugs of paclitaxel
|
|
US7288665B1
(en)
|
1997-08-18 |
2007-10-30 |
Florida State University |
Process for selective derivatization of taxanes
|
|
JPH1192468A
(ja)
|
1997-09-17 |
1999-04-06 |
Yakult Honsha Co Ltd |
新規なタキサン誘導体
|
|
WO1999018113A1
(fr)
|
1997-10-08 |
1999-04-15 |
Bio Research Corporation Of Yokohama |
Derives taxoides et leur procede de production
|
|
US5968921A
(en)
|
1997-10-24 |
1999-10-19 |
Orgegon Health Sciences University |
Compositions and methods for promoting nerve regeneration
|
|
US6486303B1
(en)
|
1998-04-14 |
2002-11-26 |
University Of Medicine & Dentistry Of New Jersey |
Method for making hormone heterodimers
|
|
US6472179B2
(en)
|
1998-09-25 |
2002-10-29 |
Regeneron Pharmaceuticals, Inc. |
Receptor based antagonists and methods of making and using
|
|
US6652864B1
(en)
*
|
1998-12-21 |
2003-11-25 |
Asilomar Pharmaceuticals, Inc. |
Compounds for intracellular delivery of therapeutic moieties to nerve cells
|
|
US20040120891A1
(en)
|
1998-12-21 |
2004-06-24 |
Craig Hill |
Compounds for intracellular delivery of therapeutic moieties to nerve cells
|
|
CA2365354A1
(en)
|
1999-03-08 |
2000-09-14 |
Gerhart Graupner |
Methods and compositions for targeted drug delivery
|
|
WO2001091798A2
(en)
|
2000-06-01 |
2001-12-06 |
Universite Catholique De Louvain |
Tumor activated prodrug compounds
|
|
US20050026823A1
(en)
|
2003-06-20 |
2005-02-03 |
Biomarin Pharmaceutical Inc. |
Use of the chaperone receptor-associated protein (RAP) for the delivery of therapeutic compounds to the brain and other tissues
|
|
WO2012028959A1
(en)
|
2010-08-31 |
2012-03-08 |
Pablo Villoslada |
Agonists of neurotrophin receptors and their use as medicaments
|
|
GB201118876D0
(en)
*
|
2011-11-01 |
2011-12-14 |
Astex Therapeutics Ltd |
Pharmaceutical compounds
|
|
HK1249051A1
(zh)
|
2015-03-06 |
2018-10-26 |
BeyondSpring Pharmaceuticals Inc. |
治疗脑肿瘤的方法
|
|
WO2016155670A1
(zh)
*
|
2015-04-01 |
2016-10-06 |
苏州晶云药物科技有限公司 |
一种cdk抑制剂和mek抑制剂的共晶及其制备方法
|
|
WO2021081206A1
(en)
|
2019-10-23 |
2021-04-29 |
Manzanita Pharmaceuticals, Inc. |
Neurotrophin receptor binding conjugate compositions, methods of use and methods of making thereof
|